Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells

Blood

Volumn 87, Issue 7, 1996, Pages 2632-2640

  Mrózek, Ewa ^b   Anderson, Paul ^b   Caligiuri, Michael A ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD34 ANTIGEN; CD56 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GENE PRODUCT; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GROWTH FACTOR; INTERLEUKIN 15; INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CONTROLLED STUDY; CYTOTOXICITY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LYMPHOCYTE DIFFERENTIATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

EID: 0029985638     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.7.2632.bloodjournal8772632     Document Type: Article

References (40)

1. Robertson MJ, Ritz J: Biology and clinical relevance of human natural killer cells. Blood 76:2421, 1990
2. Lanier LL, Spits H, Phillips JH: The developmental relationship between NK cells and T cells. Immunol Today 13:392, 1992
3. Spits H, Lanier LL, Phillips JH: Development of human T and natural killer cells. Blood 85:2654, 1995
4. - bone marrow progenitors. J Immunol 150:5263, 1993
5. - primitive progenitors in long-term bone marrow culture. Blood 80:2182, 1992
6. Silva MRG, Hoffman R, Srour EF, Ascensao JL: Generation of human natural killer cells from immature progenitors does not require marrow stromal cells. Blood 84:841, 1994
7. + hematopoietic progenitor cells. Blood 85:3538, 1995
8. Smith KA: Interleukin-2: Inception, impact and implications. Science 280:1169, 1988
9. Dorshkind K, Pollack SB, Bosma MJ, Phillips RA: Natural killer (NK) cells are present in mice with severe combined immunodeficiency (scid). J Immunol 134:3798, 1985
10. Schorle H, Holtschke T, Hünig T, Schimpl A, Horak I: Development and function of T cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352:621, 1991
11. Kündig TM, Schorle H, Bachmann MF, Hengarten H, Zinkernagel RM, Horak I: Immune responses in interleukin-2-deficient mice. Science 262:1059, 1993
12. DiSanto JP, Müller W, Guy-Grand D, Fischer A, Rajewsky K: Lymphoid development in mice with a targeted deletion of the interleukin 2 receptor γ chain. Proc Natl Acad Sci USA 92:377, 1995
13. Noguchi M, Huafang Y, Rosenblatt HM, Filipovich AH, Adelstein S, Modi WS, McBride OW, Leonard WJ: Interleukin-2 receptor γ chain mutation results in X-linked severe combined immunodeficiency in humans. Cell 73:147, 1993
14. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM, Giri JG: Cloning of a T cell growth factor that interacts with the β chain of the interleukin-2 receptor. Science 264:965, 1994
15. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Paxton R, Anderson D, Eisenman J, Grabstein K, Caligiuri MA: Interleukin (IL)15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor. J Exp Med 180:1395, 1994
16. Giri JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Kumaki S, Namen A, Park LS, Cosman D, Anderson D: Utilization of the β and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO J 13:2822, 1994
17. Anderson P, Blue ML, O'Brien C, Schlossman SF: Monoclonal antibodies reactive with the T cell receptor ζ chain: Production and charakterization using a new method. J Immunol 143:1899, 1989
18. Caligiuri MA, Zmuidzinas A, Manley TJ, Levine H, Smith K, Ritz J: Functional consequences of interleukin 2 receptor expression on resting human lymphocytes. Identification of a novel natural killer cell subset with high affinity receptors. J Exp Med 171:1509, 1990
19. 1 bone marrow stroma. Cancer Res 50:5801, 1990
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
21. Oberkircher AR, Strout MP, Herzig GP, Fritz PD, Caligiuri MA: Description of an efficient and highly informative method for evaluation of hematopoietic chimerism following allogeneic bone marrow transplantation. Bone Marrow Transplant 16:695, 1995
22. Carson WE, Ross ME, Baiocchi RA, Marien M, Baioni N, Grabstein K, Caligiuri MA: Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J Clin Invest 96:2578, 1995
23. Lanier LL, Le AM, Civin CI, Loken MR, Philips JH: The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136:4480, 1986
24. + non-MHC-restricted cytotoxic effectors from human hematopoietic precursors; requirement for c-kit ligand and interleukin-2. Proc Am Soc Clin Oncol 13:294, 1994
25. Anderson P, Caligiuri MA, Ritz J, Schlossman SF: CD3-negative natural killer cells express ζ TCR as part of a novel molecular complex. Nature 341:159, 1989
26. Anderson P, Caligiuri MA, O'Brien C, Manley T, Ritz J, Schlossman SF: Fcγ receptor type III (CD16) is included in the ζ NK receptor complex expressed by human natural killer cells. Proc Natl Acad Sci USA 87:2274, 1990
27. Lanier LL, Yu G, Philips JH: Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature 342:803, 1989
28. Cluitmans FHM, Esendam BHJ, Landegent JE, Willemze R, Falkenburg JHF: Constitutive in vivo cytokine and hematopoietic growth factor gene expression in the bone marrow and peripheral blood of healthy individuals. Blood 85:2038, 1995
29. + NK progenitor. Blood 83:2594, 1994
30. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Wiliams DA: Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89:7350, 1992
31. Heinrich MC, Dooley DC, Freed AC, Band L, Hoatlin ME, Keeble WW, Peters ST, Silvey KV, Ey FS, Kabat D, Maziarz RT, Bagby GC Jr: Constitutive expression of Steel factor gene by human stromal cells. Blood 82:771, 1993
32. Shibuya A, Kojima H, Shibuya K, Nagayoshi K, Nagasawa T, Nakauchi H: Enrichment of interleukin-2-responsive natural killer progenitors in human bone marrow. Blood 81:1819, 1993
33. Matos ME, Schnier GS, Beecher MS, Ashman LK, Wiliams DE, Caligiuri MA: Expression of a functional c-kit receptor on a subset of natural killer cells. J Exp Med 178:1079, 1993
34. Carson WE, Haldar S, Baiocchi RA, Croce CM, Caligiuri MA: The c-kit ligand suppresses apoptosis of human natural killer cells through the upregulation of bcl-2. Proc Natl Acad Sci USA 91:7553, 1994
35. + natural killer cells with high affinity inerleukin 2 receptors in human early pregnancy decidua. Int Immunol 3:743, 1991
36. Haynes BF, Martin ME, Kay HH, Kurtzberg J: Early events in human T cell ontogeny: Phenotypic characterization and lokalization of T cell precursors in early human fetal tissue. J Exp Med 168:1061, 1988
37. + bone marrow cells. J Exp Med 177:1531, 1993
38. lck kinase. Eur J Immunol 24:2527, 1994
39. Bancroft GJ: The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 4:503, 1993
40. Heremans H, Dillen C, van Damme J, Billiau A: Essential role for natural killer cells in the lethal lipopolysaccharide-induced Schwartzman-like reaction in mice. Eur J Immunol 24:1155, 1994